A polyherbal formulation was evaluated for its hepatoprotective activity against ethanol and CCl 4 induced liver damage in rats. The rats were divided into five groups of six animals each and serve as control, toxic, post-treated, herbal control, Liv.52 treated groups respectively. The results showed that the activities of liver marker enzymes in serum namely AST, ALT, ALP, ACP and serum bilirubin level (total) were increased in toxic group animals. But the activities of these enzymes were significantly lowered in post-treated group of rats. Thus, the results suggest antihepatotoxicity of "Ayush-Liv.04".
INTRODUCTION
The liver is an important organ, actively involved in many metabolic reactions and is the frequent target of number of toxicants (1) . The metabolic disorders associated with this organ are numerous and varied highly during recent years (2) . Alcohol dependency is also a major health and socio-economic problem associated with liver disorders throughout the world (3), (4) . Almost all ingested alcohol is metabolised in the liver and excessive alcohol consumption leads to acute and chronic liver disease. Most of the alcohol consumed is eventually metabolised by the liver and the products generated and accumulated during alcohol metabolism are more toxic than alcohol itself (5).
Hence, in the absence of enough number of "liver protective drugs" in the modern medicine, "Ayurveda" an Indian traditional medicinal method recommends several herbal plants for the treatment of liver disorders (6) . In recent years, there is growing interest in polyherbal formulation for the treatment of various diseases and it has enormously increased world wide (7), (8) .
A vast number of medicinal plants have traditionally been used in the ayurvedic system of medicine for the treatment of liver disorders and have been scientifically proven to have hepatoprotective properties (9) , (10) . Polyherbal formulations have shown curative effect on various diseases and disorders in rats. Hence, the present study involves the use of a polyherbal formulation "Ayush -Liv.04" which consists of four herbal plants and a copper containing milk stone against ethanol and CCl 4 induced hepatotoxicity in albino rats.
MATERIALS AND METHODS

Preparation of plant extract
A polyherbal formulation consists of four medicinal plants and a copper containing stone (milk tuttam) were prepared as crude extract by mixing the plant parts and the composition is shown in Table- I. The plants used in the present study were collected from Centre for Indian Medical Heritage (CIMH), a medicinal plant conservation park, located near the westernghats of Palghat, Kerala. Aqueous extract (6.25%) was prepared with boiling water (<100ºC) at normal pressure (11) . Then, the aqueous extract was used for the studies on laboratory animals.
Animal treatment
Albino wistar rats (160-200g) were bred in the central animal house, P.S.G. Institute of Medical College, Coimbatore-14. The animals were fed with a pellet diet [Hindustan Lever Ltd; Mumbai] and water ad libitum. The animals were maintained under 12 hrs light and at the temperature of 28°C± 2°C for 45 days.
Experimental design and animal sensitization
Animals were divided into five groups of six animals in each group. Group-I, II, III, IV and V served as control, toxic, posttreated, herbal control, and Liv.52 treated respectively. Group-II, III and group-V animals were sensitized by 40% ethanol (v/v) (2.0 ml / 100g body wt / day; orally) (12) twice per day for 21 days and a single dose of CCl 4 in liquid paraffin (1:1 ratio) on 20 th day (0.2 ml / kg body wt; ip) (13). Group-III and group-IV rats were posttreated with "Ayush-Liv.04" (4.0ml / 100g body wt / day; orally) (14) , (15) twice daily for 21 days. Group-V rats were posttreated with "Liv.52", a commercially available hepatoprotective drug (The Himalaya drug company, Bangalore, India) twice daily for 21 days (2.0 ml / 100 g body wt / day; orally) (16) .
Assessment of liver function
After 48 hours of the last day of treatment, rats of all groups were sacrificed by cervical decapitation under mild chloroform anesthesia. Blood was collected from the carotid arteries in the neck blood vessels and centrifuged at 3000 rpm for 10 minutes to separate the serum, which was kept at 4°C to assay the activities of serum enzymes. Then biochemical assays were carried out.
Biochemical analysis
The liver marker enzymes in serum alanine transaminase (ALT), aspartate transaminase (AST) (17) , serum acid phosphatase (ACP), serum alkaline phosphatase (ALP) (18) and serum bilirubin (total) (19) levels were estimated in control and experimental rats.
Statistical analysis
Results were expressed as mean ± SD and the data obtained were analysed by one way analysis of variance (ANOVA) (20) .
RESULTS AND DISCUSSION
The results are presented in Table- Kumar et al.(2005) (22) . After the treatment with "Ayush-Liv.04", group-III rats have significantly reduced the elevated serum levels of these enzymes and bilirubin. The findings of the present study are also in accordance with the study of Garg et al. (1994) (23) who reported the elevated levels of these serum enzymes in thioacetamide induced liver damage in rats. Similarly, Mukherjee et al. (1997) (24) reported an increase in serum bilirubin level in CCl 4 induced hepatotoxicity and this increase was lowered by an extract prepared from Swertia chirata on rats.
There was no significant (P<0.05) difference between normal control rats and herbal control rats. This indicates that herbal formulation does not have any deleterious effect on the rats. Similarly, when Liv.52 treated rats (group-V) were compared with post-treated rats (group-III), there was no significant (P<0.05) difference between these groups of rats. This indicates that the hepatoprotective nature of the present herbal formulation is almost equal to the standardised Liv.52 drug.
CONCLUSION
The present study provides experimental evidence for the protection of liver by "Ayush-Liv.04" without any side effects. Thus, our study has demonstrated the efficacy of the polyherbal formulation as an effective hepatoprotective agent similar to Liv.52 drug. 
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